These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 11802316)

  • 1. Intraventricular neurocysticercosis: A correlative radiopathological image.
    Mansour MA; Tahir M
    Neurol Sci; 2023 Aug; 44(8):2991-2992. PubMed ID: 37178212
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor Regarding: "Is Antihelminthics Necessary in Postoperative Treatment of Intraventricular Neurocysticercosis? A Systematic Review".
    Norcia LF; Zanini MA; Hamamoto Filho PT
    World Neurosurg; 2024 Feb; 182():229. PubMed ID: 38390886
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical analysis of 52 cases of neurocysticercosis.
    Chaoshuang L; Zhixin Z; Xiaohong W; Zhanlian H; Zhiliang G
    Trop Doct; 2008 Jul; 38(3):192-4. PubMed ID: 18628562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions.
    Pretell EJ; García HH; Gilman RH; Saavedra H; Martinez M;
    Clin Neurol Neurosurg; 2001 Oct; 103(3):175-7. PubMed ID: 11532559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First case of neurocysticercosis in Saudi Arabia.
    Al Shahrani D; Frayha HH; Dabbagh O; Al Shail E
    J Trop Pediatr; 2003 Feb; 49(1):58-60. PubMed ID: 12630724
    [No Abstract]   [Full Text] [Related]  

  • 6. [Degenerating neurocysticercosis cysts: differential diagnosis with cerebral metastasis].
    Coulibaly B; Gautier G; Fuentes S; Ranque S; Bouvier C
    Rev Neurol (Paris); 2008 Nov; 164(11):948-52. PubMed ID: 18808758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst.
    Bustos JA; Pretell EJ; Llanos-Zavalaga F; Gilman RH; Del Brutto OH; Garcia HH;
    Clin Neurol Neurosurg; 2006 Feb; 108(2):193-4. PubMed ID: 16412842
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurocysticercosis.
    Lev N; Michowiz S; Inbar E; Coire CI; Pitlik S; Melamed E
    Isr Med Assoc J; 2002 Jan; 4(1):65-6. PubMed ID: 11802316
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brain cysticercosis: review and case report].
    Sabbatani S; Fasulo G; Chiodo F
    Infez Med; 2003 Dec; 11(4):175-82. PubMed ID: 14988664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacoeconomic analysis of the short scheme praziquantel in the treatment of neurocysticercosis].
    Medina-Santillán R; Mateos-García E; Reyes-García G; Castañeda-Hernández G; Sotelo J
    Gac Med Mex; 2002; 138(2):203-7. PubMed ID: 12001432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
    Jung-Cook H
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.